Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Biochimica Et Biophysica Acta
|
August 18, 2009
Chromosomal tethering and proviral integration
Olivier Delelis, Alessia Zamborlini, Sylvain Thierry, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
June 30, 2006
Activation of sPLA2-IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-1beta
Amandine Jaulmes, Sylvain Thierry, Brigitte Janvier, et al.
Retrovirology
|
August 14, 2013
Quantitative analysis of the time-course of viral DNA forms during the HIV-1 life cycle
Soundasse Munir, Sylvain Thierry, Frédéric Subra, et al.
Cancer Research
|
June 8, 2017
Micronuclei Frequency in Tumors Is a Predictive Biomarker for Genetic Instability and Sensitivity to the DNA Repair Inhibitor AsiDNA
Wael Jdey, Sylvain Thierry, Tatiana Popova, et al.
Molecular Cancer Therapeutics
|
September 27, 2017
The DNA Repair Inhibitor Dbait Is Specific for Malignant Hematologic Cells in Blood
Sylvain Thierry, Wael Jdey, Solana Alculumbre, et al.
AIDS (London, England)
|
January 27, 2007
High-mobility group box 1 protein induces HIV-1 expression from persistently infected cells
Sylvain Thierry, Joël Gozlan, Amandine Jaulmes, et al.
Journal of Virology
|
October 28, 2004
Cell cycle arrest in G2 induces human immunodeficiency virus type 1 transcriptional activation through histone acetylation and recruitment of CBP, NF-kappaB, and c-Jun to the long terminal repeat promoter
Sylvain Thierry, Vincent Marechal, Michelle Rosenzwajg, et al.
Scientific Reports
|
May 12, 2016
Opposite transcriptional regulation of integrated vs unintegrated HIV genomes by the NF-κB pathway
Sylvain Thierry, Eloïse Thierry, Frédéric Subra, et al.
Neoplasia (New York, N.Y.)
|
July 31, 2019
AsiDNA Treatment Induces Cumulative Antitumor Efficacy with a Low Probability of Acquired Resistance
Wael Jdey, Maria Kozlak, Sergey Alekseev, et al.
Frontiers in Oncology
|
November 30, 2019
Preclinical Studies Comparing Efficacy and Toxicity of DNA Repair Inhibitors, Olaparib, and AsiDNA, in the Treatment of Carboplatin-Resistant Tumors
Nirmitha I Herath, Nathalie Berthault, Sylvain Thierry, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Biochimica Et Biophysica Acta
|
August 18, 2009
Chromosomal tethering and proviral integration
Olivier Delelis, Alessia Zamborlini, Sylvain Thierry, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
June 30, 2006
Activation of sPLA2-IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-1beta
Amandine Jaulmes, Sylvain Thierry, Brigitte Janvier, et al.
Retrovirology
|
August 14, 2013
Quantitative analysis of the time-course of viral DNA forms during the HIV-1 life cycle
Soundasse Munir, Sylvain Thierry, Frédéric Subra, et al.
Cancer Research
|
June 8, 2017
Micronuclei Frequency in Tumors Is a Predictive Biomarker for Genetic Instability and Sensitivity to the DNA Repair Inhibitor AsiDNA
Wael Jdey, Sylvain Thierry, Tatiana Popova, et al.
Molecular Cancer Therapeutics
|
September 27, 2017
The DNA Repair Inhibitor Dbait Is Specific for Malignant Hematologic Cells in Blood
Sylvain Thierry, Wael Jdey, Solana Alculumbre, et al.
AIDS (London, England)
|
January 27, 2007
High-mobility group box 1 protein induces HIV-1 expression from persistently infected cells
Sylvain Thierry, Joël Gozlan, Amandine Jaulmes, et al.
Journal of Virology
|
October 28, 2004
Cell cycle arrest in G2 induces human immunodeficiency virus type 1 transcriptional activation through histone acetylation and recruitment of CBP, NF-kappaB, and c-Jun to the long terminal repeat promoter
Sylvain Thierry, Vincent Marechal, Michelle Rosenzwajg, et al.
Scientific Reports
|
May 12, 2016
Opposite transcriptional regulation of integrated vs unintegrated HIV genomes by the NF-κB pathway
Sylvain Thierry, Eloïse Thierry, Frédéric Subra, et al.
Neoplasia (New York, N.Y.)
|
July 31, 2019
AsiDNA Treatment Induces Cumulative Antitumor Efficacy with a Low Probability of Acquired Resistance
Wael Jdey, Maria Kozlak, Sergey Alekseev, et al.
Frontiers in Oncology
|
November 30, 2019
Preclinical Studies Comparing Efficacy and Toxicity of DNA Repair Inhibitors, Olaparib, and AsiDNA, in the Treatment of Carboplatin-Resistant Tumors
Nirmitha I Herath, Nathalie Berthault, Sylvain Thierry, et al.
Page
of 3